Fri, Oct 24, 2014, 6:37 AM EDT - U.S. Markets open in 2 hrs 53 mins


% | $
Quotes you view appear here for quick access.

Discovery Laboratories Inc. Message Board

  • jimmye123 jimmye123 Jun 11, 2013 8:42 AM Flag

    PRoduction Freeze Offs

    Discovery Labs Issues Final Assessment of Reintubation on Healthcare Costs, Says Infants Treated with Surfaxin Survival Higher without Intubation
    7:48a ET June 11, 2013 (Benzinga)
    Discovery Laboratories, Inc.(NASDAQ: DSCO) today announced the presentation of the last in a series ofpharmacoeconomic analyses indicating that a reduction in the rate ofreintubation ^ among preterm infants may potentially result in hospitalcost-savings related to fewer reintubation-related diagnoses ofbronchopulmonary dysplasia (BPD), air leak, sepsis, necrotizing enterocolitis(NEC), or intraventricular hemorrhage (IVH), including savings of up to$562,000 per 100 patients diagnosed with BPD. The pharmacoeconomic model wasdeveloped using an observation from a previously published study that preterminfants who receive SURFAXIN® may have lower rates of reintubation whencompared with preterm infants who received either Curosurf® ^ or Survanta®.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.92+0.04(+2.13%)Oct 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Flotek Industries Inc.
NYSEThu, Oct 23, 2014 4:04 PM EDT
Pfizer Inc.
NYSEThu, Oct 23, 2014 4:00 PM EDT